MediClin AG (STU:MED) E10: €0.20 (As of Mar. 2026)


STU:MED MediClin AG STU:MED
78 GF Score
Price €3.84
GF Value €2.95
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is MediClin AG E10?

MediClin AG STU:MED -0.52% 78 E10 is €0.20 as of Mar. 2026. GuruFocus rates STU:MED with a GF Score™ of 78/100 and a GF Value™ of €2.95 (Modestly Overvalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

MediClin AG's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.070. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.20 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 8.20% per year. During the past 5 years, the average E10 Growth Rate was 11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of MediClin AG was 12.30% per year. The lowest was -9.80% per year. And the median was 4.10% per year.

As of today (2026-06-28), MediClin AG's current stock price is €3.84. MediClin AG's E10 for the quarter that ended in Mar. 2026 was €0.20. MediClin AG's Shiller PE Ratio of today is 19.20.

During the past 13 years, the highest Shiller PE Ratio of MediClin AG was 46.00. The lowest was 13.79. And the median was 28.92.


MediClin AG  (STU:MED) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

MediClin AG's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=3.84/0.20
=19.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of MediClin AG was 46.00. The lowest was 13.79. And the median was 28.92.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


MediClin AG E10 Related Terms


MediClin AG E10 Historical Data

* Premium members only.

The historical data trend for MediClin AG's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MediClin AG E10 Chart

MediClin AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.12 0.13 0.13 0.16 0.18

MediClin AG Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.19 0.19 0.18 0.20

STU:MED vs HCA, THC, DVA: E10 Comparison

For the Medical Care Facilities subindustry, MediClin AG's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where MediClin AG's Shiller PE Ratio falls into.


STU:MED
78GF Score
MediClin AG STU:MED
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

MediClin AG E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, MediClin AG's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.07/131.2583*131.2583
=0.070

Current CPI (Mar. 2026) = 131.2583.

MediClin AG Quarterly Data

per share eps CPI Adj_EPS
201606 0.110 100.717 0.143
201609 0.130 101.017 0.169
201612 0.090 101.217 0.117
201703 -0.020 101.417 -0.026
201706 0.100 102.117 0.129
201709 0.240 102.717 0.307
201712 -0.240 102.617 -0.307
201803 0.005 102.917 0.006
201806 0.080 104.017 0.101
201809 0.160 104.718 0.201
201812 -0.090 104.217 -0.113
201903 -0.020 104.217 -0.025
201906 0.040 105.718 0.050
201909 0.106 106.018 0.131
201912 0.080 105.818 0.099
202003 -0.110 105.718 -0.137
202006 -0.120 106.618 -0.148
202009 0.140 105.818 0.174
202012 -0.100 105.518 -0.124
202103 -0.240 107.518 -0.293
202106 -0.080 108.486 -0.097
202109 0.230 109.435 0.276
202112 0.130 110.384 0.155
202203 -0.080 113.968 -0.092
202206 0.130 115.760 0.147
202209 0.040 118.818 0.044
202212 0.110 119.345 0.121
202303 -0.130 122.402 -0.139
202306 0.230 123.140 0.245
202309 0.220 124.195 0.233
202312 -0.550 123.773 -0.583
202403 -0.030 125.038 -0.031
202406 0.040 125.882 0.042
202409 0.300 126.198 0.312
202412 0.210 127.041 0.217
202503 0.000 127.779 0.000
202506 0.200 128.412 0.204
202509 0.330 129.255 0.335
202512 0.010 129.361 0.010
202603 0.070 131.258 0.070

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €0.20 mean?
MediClin AG (STU:MED) has a E10 of €0.20 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on MediClin AG and its competitors.
Is MediClin AG's E10 too high?
MediClin AG's current E10 is €0.20. Overall, MediClin AG has a GF Score™ of 78/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does MediClin AG's E10 compare to HCA and THC?
MediClin AG's E10 of €0.20 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on MediClin AG and its competitors. MediClin AG's current E10 is €0.20. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MediClin AG stock overvalued right now?
Based on GuruFocus' analysis, MediClin AG (STU:MED) is currently considered Modestly Overvalued. The stock's GF Value™ is €2.95, compared to a current price of €3.84 — trading 30.2% above its estimated fair value. The current E10 is €0.20. MediClin AG's overall GF Score™ is 78/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For MediClin AG (STU:MED), the current E10 is €0.20 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is MediClin AG (STU:MED) Overvalued in 2026?

Based on GuruFocus' analysis, MediClin AG stock appears to be overvalued. The current stock price of €3.84 is trading 30.2% above its estimated GF Value™ of €2.95. GuruFocus considers MediClin AG to be Modestly Overvalued.

Key valuation signals for STU:MED:

  • E10: €0.20
  • GF Value™: €2.95 vs. price of €3.84 (30.2% above fair value)
  • GF Score™: 78/100 with 5 warning signs

No single metric tells the full story. See the STU:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


MediClin AG Business Description

Other Exchanges 0NDG:UKMED:Germany
Address Okenstrasse 27, Offenburg, BW, DEU, 77652
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
78GF Score

Get the complete analysis for STU:MED

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.84
Price
€2.95
GF Value